Establishment Labs Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Establishment Labs stock.
View analyst ratings for Establishment Labs or view top-rated stocks.

Wall Street analysts have given Establishment Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Establishment Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Establishment Labs is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Establishment Labs.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) issued its quarterly earnings results on Thursday, July, 29th. The company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.28) by $0.06. The firm had revenue of $31.99 million for the quarter, compared to the consensus estimate of $31.50 million. Establishment Labs had a negative net margin of 19.78% and a negative trailing twelve-month return on equity of 29.92%.
View Establishment Labs' earnings history.

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA shares have increased by 365.5% and is now trading at $70.53.
View which stocks have been most impacted by COVID-19.

Establishment Labs issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $122 million-$126 million, compared to the consensus revenue estimate of $120.91 million.

4 brokerages have issued 12-month price objectives for Establishment Labs' stock. Their forecasts range from $78.00 to $90.00. On average, they expect Establishment Labs' stock price to reach $84.50 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts' price targets for Establishment Labs or view top-rated stocks among Wall Street analysts.

Some companies that are related to Establishment Labs include MSA Safety (MSA), Avanos Medical (AVNS), Inogen (INGN), Eargo (EAR), D8 (DEH), Sientra (SIEN), Conformis (CFMS), Sanara MedTech (SMTI), United Health Products (UEEC), Invacare (IVC), Lakeland Industries (LAKE), Surgalign (SRGA), Milestone Scientific (MLSS), Alpha Pro Tech (APT) and CollPlant Biotechnologies (CLGN).
View all of ESTA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager.

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (8.12%), Perceptive Advisors LLC (2.95%), Perceptive Advisors LLC (2.95%), Nicholas Investment Partners LP (0.99%), Kornitzer Capital Management Inc. KS (0.77%) and Citadel Advisors LLC (0.00%). Company insiders that own Establishment Labs stock include Dennis E Condon, Dennis E Condon, Jw Asset Management, Llc, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Renee Gaeta and Santos Salvador Dada.
View institutional ownership trends for Establishment Labs.

ESTA stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Perceptive Advisors LLC, Nantahala Capital Management LLC, Tygh Capital Management Inc., Morgan Stanley, Morgan Stanley, Cambridge Investment Research Advisors Inc., and Rice Hall James & Associates LLC. Company insiders that have sold Establishment Labs company stock in the last year include Dennis E Condon, Lisa Gersh, Mezerville Roberto De, Quiros Juan Jose Chacon, Renee Gaeta, and Santos Salvador Dada.
View insider buying and selling activity for Establishment Labs or view top insider-selling stocks.

ESTA stock was bought by a variety of institutional investors in the last quarter, including Nicholas Investment Partners LP, Allianz Asset Management GmbH, BlackRock Inc., Swiss National Bank, Millennium Management LLC, Landsberg Bennett & Dubbaneh LLC, Calamos Advisors LLC, and Renaissance Technologies LLC. Company insiders that have bought Establishment Labs stock in the last two years include Jw Asset Management, Llc, Mezerville Roberto De, and Nicholas Sheridan Lewin.
View insider buying and selling activity for Establishment Labs or or view top insider-buying stocks.

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ESTA stock can currently be purchased for approximately $70.53.

Establishment Labs has a market capitalization of $1.67 billion and generates $84.68 million in revenue each year. The company earns $-38,120,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

Establishment Labs employs 521 workers across the globe.

The official website for Establishment Labs is www.establishmentlabs.com.

Establishment Labs is headquartered at Building B15 and 25 Coyol Free Zone, Alajuela G2, .

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at (062) 434-2400 or via email at [email protected].